Literature DB >> 9226892

Helicobacter rodentium sp. nov., a urease-negative Helicobacter species isolated from laboratory mice.

Z Shen1, J G Fox, F E Dewhirst, B J Paster, C J Foltz, L Yan, B Shames, L Perry.   

Abstract

A spiral-shaped bacterium with bipolar, single, nonsheathed flagella was isolated from the intestines of laboratory mice. The organism grew at 37 and 42 degrees C under microaerobic and anaerobic conditions, did not hydrolyze urea, was weakly positive for catalase and oxidase, reduced nitrate to nitrite, did not hydrolyze indoxyl acetate or hippurate, and was resistant to cephalothin and nalidixic acid. This is the first urease-negative, murine Helicobacter spp. isolated from intestines. Also, Helicobacter pullorum and this bacterium are unique among the genus Helicobacter in having nonsheathed flagella. The new bacterium appears to be part of the normal intestinal flora; although its pathogenic potential is unknown, this organism was also isolated from scid mice with diarrhea that were co-infected with Helicobacter bilis. On the basis of 16S rRNA gene sequence analysis data and biochemical and phenotypic criteria, the new organism is classified as a novel helicobacter, for which we propose the name Helicobacter rodentium. The type strain is MIT 95-1707 (= ATCC 700285).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226892     DOI: 10.1099/00207713-47-3-627

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  42 in total

1.  Species differentiation and identification in the genus of Helicobacter.

Authors:  Jie-Song Hua; Peng-Yuan Zheng; HO Bow
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

2.  Development of a simple and rapid method based on polymerase chain reaction-based restriction fragment length polymorphism analysis to differentiate Helicobacter, Campylobacter, and Arcobacter species.

Authors:  A González; Y Moreno; R González; J Hernández; M A Ferrús
Journal:  Curr Microbiol       Date:  2006-10-19       Impact factor: 2.188

3.  Differential detection of five mouse-infecting helicobacter species by multiplex PCR.

Authors:  Sunlian Feng; Karin Ku; Emir Hodzic; Edward Lorenzana; Kim Freet; Stephen W Barthold
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

4.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

5.  Isolation of Helicobacter spp. from mice with rectal prolapses.

Authors:  Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; James G Fox
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

6.  Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen.

Authors:  J G Fox; C C Chien; F E Dewhirst; B J Paster; Z Shen; P L Melito; D L Woodward; F G Rodgers
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 7.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

8.  Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.

Authors:  Maciej Chichlowski; Julie M Sharp; Deborah A Vanderford; Matthew H Myles; Laura P Hale
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

9.  High prevalence of Helicobacter Species detected in laboratory mouse strains by multiplex PCR-denaturing gradient gel electrophoresis and pyrosequencing.

Authors:  Hans-Olof Nilsson; Ibn-Sina Ouis; Unne Stenram; Asa Ljungh; Anthony P Moran; Torkel Wadström; Waleed Abu Al-Soud
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.

Authors:  Maciej Chichlowski; Greg S Westwood; Soman N Abraham; Laura P Hale
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.